Answers are grounded in this paper and cite their sources.
Differentiation syndrome from retinoic acid therapy can rarely present with acute myocarditis, which can be diagnosed using cardiac magnetic resonance imaging.
A 36-year-old male with acute promyelocytic leukaemia was commenced on a regimen consisting of all-transretinoic acid (ATRA) and arsenic tetraoxide (ATO) chemotherapy at our institution. On Day 2, he developed central chest pain. Clinical examination and vital observations were unremarkable. A 12-lead electrocardiogram showed normal sinus rhythm with no ischaemic changes. Subsequent blood tests revealed a dynamic rise in troponin I from 1063 ng/L to 14 387 ng/L (<57 ng/L), raised d-dimer of 6862 ng/mL (<220 ng/mL), and procalcitonin of 0.35 µg/L (<0.5 µg/L). A respiratory virus polymerase chain reaction (PCR) screen and two SARS-CoV2 PCR tests performed 5 days apart were negative. Blood and urine cultures were unremarkable. Coronary angiography did not show significant coronary artery stenosis (Supplementary data online, Videos S1–S3). Transthoracic echocardiography showed preserved biventricular systolic function (Supplementary data online, Videos S4 and S5). Cardiac magnetic resonance (CMR) demonstrated globally raised myocardial native T1 of 1248 ms (930–1000 ms) (Panel A), global myocardial oedema (Panel B), and mid-wall late gadolinium hyperenhancement in the basal-mid septal and mid-inferolateral segments of the left ventricle (LV) (Panels C and D), typical features of acute myocarditis. In the absence of infection, a diagnosis of ATRA-induced differentiation syndrome with acute myocarditis was made. As the dose of ATO was therapeutic, it was felt unlikely to be the primary contributor. ATRA was withheld for two doses before being re-introduced at a lower dose. The patient improved symptomatically, and troponin I levels returned to normal. Differentiation syndrome is a complication of retinoic acid therapy and is rarely associated with myocarditis. The case demonstrates the CMR features associated with this diagnosis. (Panel A) Diffusely elevated T1 on mid-ventricular CMR T1 map. (Panel B) T2 weighted CMR imaging showing diffuse myocardial oedema. (Panel C) Basal short-axis slice on CMR imaging showing septal and inferolateral mid-wall fibrosis. (Panel D) Left ventricular outflow tract view on CMR imaging showing mid-wall fibrosis in the basal-mid anterior septal and mid-inferolateral segments of the LV. Supplementary data are available at European Heart Journal - Cardiovascular Imaging online.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: